|Venture Round, 1/07 |
IP Group Plc
White Rose Technology Seedcorn Fund
Tissue Regenix was founded in May 2006, to commercialise innovative technologies in regenerative medicine. The underpinning science was developed over the last decade in the world-leading Institute for Medical and Biological Engineering at the University of Leeds by Professors John Fisher and Eileen Ingham. The research has received in excess of Â£4 million grant funding to date from UK research councils (EPSRC, BBSRC) and the Children’s Heart Surgery Fund.